Hodgkin Disease

Showing 26 - 50 of 91

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Disease Trial in Worldwide (Nivolumab, Doxorubicin, Vinblastine)

Active, not recruiting
  • Hodgkin Disease
  • Los Angeles, California
  • +37 more
Oct 25, 2021

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)

Terminated
  • Hodgkin Disease
  • Lymphoma, Non-hodgkin
  • New York, New York
    Columbia University Irving Medical Center - Center for Lymphoid
Jun 28, 2021

Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Taiwan (TG-0054 (2.24 mg/kg), TG-0054 (3.14 mg/kg))

Completed
  • Multiple Myeloma
  • +2 more
  • TG-0054 (2.24 mg/kg)
  • TG-0054 (3.14 mg/kg)
  • Chiayi, Taiwan
  • +5 more
Apr 14, 2021

Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Stony Brook, Nashville (TG-0054 combined with G-CSF)

Completed
  • Multiple Myeloma
  • +2 more
  • TG-0054 combined with G-CSF
  • Stony Brook, New York
  • +1 more
Apr 14, 2021

Hodgkin Disease Trial in Saint Louis, Winston-Salem, Columbus (Lenalidomide)

Completed
  • Hodgkin Disease
  • Saint Louis, Missouri
  • +2 more
Mar 9, 2021

Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma

Completed
  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin
  • Survey
  • Rochester, New York
    University of Rochester Medical Center
Mar 4, 2021

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic Trial in China (Brentuximab Vedotin)

Completed
  • Hodgkin Disease
  • Lymphoma, Large-Cell, Anaplastic
  • Brentuximab Vedotin
  • Beijing, Beijing, China
  • +6 more
Feb 3, 2021

Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma Trial in United States (TXA127, Placebo)

Terminated
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Duarte, California
  • +9 more
Dec 7, 2020

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hodgkin Disease Trial in Chicago, Saint Louis (Romidepsin,

Completed
  • Lymphoma, T-Cell, Cutaneous
  • +3 more
  • Chicago, Illinois
  • +1 more
Nov 16, 2020

Occupational Status and Hematological Disease

Completed
  • Chronic Myeloid Leukemia
  • +4 more
  • Study questionnaire
  • SF-36 Questionnaire
  • Bari, Italy
  • +4 more
Oct 5, 2020

Hodgkin Disease Trial (Lenalidomide (Revlimid®))

Completed
  • Hodgkin Disease
  • Lenalidomide (Revlimid®)
  • (no location specified)
Sep 16, 2020

Hodgkin Disease, Non Hodgkin Lymphoma, Lymphoepithelioma Trial in Houston (LMP1/2 CTLs (ALCI - Group A), LMP1/2 CTLs (ALCI -

Completed
  • Hodgkin Disease
  • +3 more
  • LMP1/2 CTLs (ALCI - Group A)
  • +8 more
  • Houston, Texas
  • +1 more
May 26, 2020

Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,

Unknown status
  • Classical Hodgkin Lymphoma
  • +3 more
  • Riyadh, Saudi Arabia
    King Abdulaziz Medical City, Ministry of National Guard
Nov 14, 2019

Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in Turku (68Ga-DOTANOC PET/CT; Diffusion weighted MRI)

Completed
  • Lymphoma
  • +2 more
  • 68Ga-DOTANOC PET/CT; Diffusion weighted MRI
  • Turku, Finland
    Turku University Hospital
Jun 18, 2019

Hodgkin Disease Trial in United States (brentuximab vedotin, bendamustine)

Completed
  • Hodgkin Disease
  • Birmingham, Alabama
  • +12 more
Jan 24, 2019

Hodgkin Disease Trial in Houston (Filgrastim SD/01, Adriamycin, Bleomycin)

Completed
  • Hodgkin Disease
  • Filgrastim SD/01
  • +4 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

Hodgkin Disease, Lymphoma, Non-Hodgkin, Tumors Trial (MK-8776, Gemcitabine)

Completed
  • Hodgkin Disease
  • +2 more
  • (no location specified)
Jul 26, 2018

Hodgkin Disease Trial in United Kingdom (Brentuximab Vedotin)

Completed
  • Hodgkin Disease
  • Brentuximab Vedotin
  • Birmingham, United Kingdom
  • +11 more
May 9, 2018

Non Hodgkin's Lymphoma, Hodgkin Disease, Multiple Myeloma Trial in Boston (Fludarabine and total body irradiation, Total body

Terminated
  • Non Hodgkin's Lymphoma
  • +2 more
  • Fludarabine and total body irradiation
  • Total body irradiation
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 26, 2018

Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in Saint Louis (Carmustine, Etoposide phosphate, Cytarabine)

Completed
  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 16, 2018

Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Minneapolis (Leuprolide, hematopoietic cell transplant, reduced

Terminated
  • Multiple Myeloma
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Defining PET / CT Protocols With Optimized F18-FDG Dose,

Completed
  • Malignant Neoplasm of Breast
  • +7 more
  • Image quantify
  • Salvador, Bahia, Brazil
    Hospital Sao Rafael
Nov 27, 2017

Consent for Obtaining Additional Tissue at Time ofDiagnostic

Completed
  • Lymphoma
  • Hodgkin Disease
  • tumor tissue aspiration
  • phlebotomy
  • Stanford, California
    Stanford University School of Medicine
Nov 16, 2017